Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Insys Therapeutics Inc. INSYQ

Insys Therapeutics Inc is a specialty pharmaceutical company. It develops and commercializes innovative drugs and novel drug delivery systems of therapeutic molecules that improve patients' quality of life. The company have two marketed products; SUBSYS, a proprietary sublingual fentanyl spray; and SYNDROS, a proprietary orally administered liquid formulation of dronabinol. The company derives... see more

Bullboard (OTCPK:INSYQ)

View:
Post by Gmoney$on Jun 14, 2019 10:41am

Bankruptcy

So from what I understand they are filing Bankruptcy so that they can't get sued anymore but can continue operations. Is this correct? 
Post by coolfooldumbguyon Jun 13, 2019 11:38am

it's a buy today for me

looking for a DEAD CAT BOUNCE after the BIG selloff,so glta.
Post by Cannabedson Sep 04, 2018 8:04am

Clinical Study Collaboration

https://www.ftmig.com/cannabis-marijuana/insys-therapeutics-and-uc-san-diegos-center-for-medicinal-cannabis-research-expand-collaboration-to-include-clinical-study-of-cannabidiol-in-early-psychosis/  ...more  
Comment by Hunter999on Aug 23, 2018 9:30pm

RE:Up 17% on news that INSY settles with $150 mil payment

Is the means the company can move forward  which is a good sign 
Post by GrimesInvestoron May 04, 2018 11:05pm

What's going on here?

New to board. Notice HMMJ is still being a decent amount of this stock. What do you guys think is holding it down so much right now? Thanks
Comment by Sped1111on Nov 20, 2017 1:28pm

RE:RE:Check out TBP

This board seems to be kind of quiet as of late. This news sounds positive for getting the price back on a positive track. 
Comment by TripleEmon Sep 18, 2017 11:09pm

RE:Check out TBP

https://tetrabiopharma.com/investors/press-releases/press-release-details/2017/Tetra-Bio-Pharma-getting-ready-to-file-a-clinical-trial-application-to-initiate-phase-3-clinical-trial-on-terminal-cancer ...more  
Post by TripleEmon Sep 18, 2017 10:28pm

Check out TBP

Great price, under valued, JMO, GLTA...
Post by Qczar417on Apr 19, 2017 9:56pm

Cashing in on Canada's $30 billion dollar marijuana boom

A new commodity boom is coming to Canada. And this time, it is going to be a green rush. Marijuana is expected to be legalized in the country this year. And the market could be worth nearly $23 ...more  
Post by Weedcapitalon Nov 08, 2016 9:01am

PUF - MMPR licence pending anyday - most undervalued play

PUF  only 30,000,000 o/s float this can easily run to $2  MMRP licence approval announcement can come anyday Legitate company with grow facility in place and revenue producing vape brand  ...more  
Post by Investgod99on Nov 07, 2016 3:13pm

ACG up 37% - running - legit MMPR player BREAKOUT

Read up on ACG -- this is a solid innovative MMPR company Only 33million shares outstanding. $1 is in the horizon
Post by MilanMalhi18on Nov 06, 2016 1:54am

Kushtown new marijuana listing on CSE

It looks like kushtown is well established in the California cannabis market lots of good google history and excellent reviews of their products   https://www.stockwatch.com/News/Item.aspx ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities